[1]
2024. Quantitative Structure Activity Relationship Studies of Potent Endothelin-A Receptor Antagonist for the Treatment of Pulmonary Arterial Hypertension. Indian Journal of Chemistry (IJC). 63, 2 (Feb. 2024), 190–202. DOI:https://doi.org/10.56042/ijc.v63i2.6141.